HealthVerity
Leading the Healthcare Industry in Privacy Management & Interoperability

HealthVerity appoints John Eckhart as Chief Technology Officer

Monday, September 25, 2023

Award-winning SaaS product developer to lead HealthVerity in continuing to move the healthcare market forward

PHILADELPHIA - HealthVerity, the leader in synchronizing transformational technologies and real-world data (RWD) to advance the science, announced that John Eckhart has been appointed Chief Technology Officer (CTO). With over 15 years of experience working with startup and growth-stage technology companies to innovate and develop leading SaaS products, Eckhart joins the HealthVerity leadership team with a focus on delivering compelling solutions that fully manage identity, privacy and compliance for customers.

Prior to joining HealthVerity, John worked at 15Five, a human resources technology company recognized for their technology products that help companies deliver on HR business outcomes. Eckhart has developed award-winning products at renowned companies, such as Yodle and Nearpod, that innovated and shaped their respective industries. Prior to that, he led efforts building massive trading and market data systems for JP Morgan. He has built data-intensive SaaS applications that catalyzed double and triple-digit customer growth in organizations spanning healthcare, financial and education sectors.

"I'm very pleased to welcome John Eckhart to HealthVerity as our new CTO," said Andrew Kress, HealthVerity CEO. "We're excited to have him join us at a pivotal time as we continue to develop innovative tools, software, and methods to make healthcare data available and usable for research and analytics. The future is going to be about seamlessly synchronizing the right patient-centric data to the right analytic in a highly efficient manner to answer key commercial and evidence questions. The HealthVerity team is looking forward to having John as a copilot as we roll out new tools and data over the next year."

Eckhart looks forward to combining his expertise in quickly developing products with the dedicated HealthVerity team of data experts to bring increased innovation. "The healthcare data exchange model that HealthVerity pioneered is already moving the market forward," Eckhart said. "I see great opportunity for us to continue this market progression. Our customers are doing groundbreaking work, developing new drugs, conducting clinical trials and tracking progression of infectious diseases. By equipping them with the right technology and tools, such as HealthVerity FLOW, our clients can have even more impact on people's lives."

HealthVerity launches its Mortality Masterset, powered by Veritas Data Research, to provide the most likely cause of death for health outcomes research

Wednesday, November 08, 2023

PHILADELPHIA, -- HealthVerity, the leader in synchronizing transformational technologies and real-world data (RWD) to advance the science, announced the launch of the expertly curated HealthVerity Mortality Masterset, powered by Veritas Data Research.

The solution synchronizes Veritas' Fact of Death dataset, consisting of over 130 million death records from 1935 to today derived from more than 40,000 public and private sources, with a syndicate of open and closed medical claims assembled by HealthVerity from the nation's largest de-identified healthcare and consumer data ecosystem. An advanced analytics engine empowered by deterministic and rules-based algorithms processes this synchronized data, retracing each patient's medical history back 36 months prior from the date of passing, to determine the most likely primary and secondary causes of death. Additionally, each individual is de-identified using a universal HealthVerity ID that allows the Mortality Masterset to be seamlessly synchronized with other data sources for a comprehensive view of the patient journey.

It is important to know not just if a patient died, but whether the cause of death was from the disease being studied to better measure treatment efficacy and overall survival, address any safety issues, and make appropriate public health policy decisions. While cause of death is captured in death certificates that are collected by states and passed onto the CDC, access to these records is restricted, can take up to a year or more to receive, and they are not de-identified or interoperable. Additionally, the cause of death listed on the death certificate is often prone to error, with peer reviewed studies showing error rates ranging from 34% to 52% or even higher.1 Additionally, cardiac events are over reported on death certificates as a catchall when the true cause of death is unknown.

"Death is a critical endpoint in health research and related disciplines; however, the cause of death is rarely available in public notices and is often inaccurate in official death certificates," explained Veritas CEO Jason LaBonte. "The Mortality Masterset offering is the first widely-accessible dataset to include cause of death for health research and risk modeling."

"We saw a need amongst our clients in the life sciences industry to have an accurate cause of death for long-term follow up and health outcome studies, and we're happy to be able to partner with Veritas to create the Mortality Masterset," said Andrew Kress, HealthVerity CEO. "By synchronizing this breadth and depth of de-identified data, we are able to provide the most accurate, pre-assembled cause of death determination in a HIPAA-compliant format that allows our clients to start their studies immediately, without having to do additional research on the cause of death."

The Mortality Masterset is an addition to the growing suite of HealthVerity Mastersets, including the Provider Diversity and Diagnosis Index (PDI) Masterset, Maternal Outcomes Masterset (MOM), Chronic Kidney Disease (CKD) Masterset, and COVID-19 Masterset, all of which are curated by RWD experts to provide speed to insight for a particular area of study.

Healthverity Introduces Taxonomy, the Nation's Most Comprehensive Closed Claims Dataset for Pharmaceutical Research

Tuesday, June 25, 2024

PHILADELPHIA- HealthVerity, the leader in synchronizing transformational technologies and real-world data (RWD) to advance the science, today announced the launch of HealthVerity taXonomy - the nation's most comprehensive, highly-curated and research-ready closed claims dataset for pharmaceutical safety, real-world evidence, and health economics and outcomes research organizations. This next-generation data solution meets the needs of an industry facing headwinds with evolving and unstable access to HIPAA-compliant patient data that is critical to justifying the cost, effectiveness and safety of increasingly complex treatments. HealthVerity taXonomy overcomes these challenges while providing unparalleled insights into patient journeys, treatment outcomes and total cost of care.

Breaking from legacy solutions that rely on a narrow mix of payers and payer types, HealthVerity taXonomy is an easy-to-use dataset specifically designed for research that encompasses over 245 million patient journeys from more than 225 payers, including commercial, Medicare and Medicaid, as well as race and mortality markers. The expansive dataset has up to eight years of continuous coverage, inclusive of all age groups, races and geographies. These attributes ensure a superior volume of rare and orphan diseases compared to legacy solutions, allowing for more impactful research outcomes. Through HealthVerity's curation process, researchers benefit from organized, well-structured, de-duplicated patient encounters, reducing data management time and complexity.

Addressing a disruptive trend in data access, HealthVerity taXonomy is built for the long-term with a matrix approach to data providers that maximizes data breadth and stability while minimizing data disruption. HealthVerity has lasting relationships with all of the data providers in the nation's largest healthcare and consumer data ecosystem that leads to a seamless data experience for its clients. Moreover, the open HealthVerity data ecosystem continually supports new payers and fully interoperable data types, such as electronic medical records and lab results, ensuring that HealthVerity taXonomy can solve for the most challenging of research questions in the most consistent, well characterized and highly relevant manner.

HealthVerity taXonomy also includes improved standardized costs mapped to procedures for any geography or payer type, including relevant market averages. This level of cost standardization enables pharmaceutical companies to better understand the pricing and value of medical treatments and total cost of care, ultimately leading to improved results.

HealthVerity taXonomy offers a newly streamlined and industry-leading data model with all data attributes being fully synchronized, de-duped and HIPAA-certified. This makes HealthVerity taXonomy research-ready from day one. The HIPAA certification also covers any future payer and data type additions from HealthVerity, ensuring continued compliance with privacy regulations while avoiding lengthy privacy delays in gaining access to new patient insights.

"With the changing pharmaceutical and healthcare data landscape, researchers can no longer afford to rely on legacy closed claims datasets derived from limited data sources and lacking key attributes from commercial, Medicare and Medicaid patients," said Andrew Kress, CEO of HealthVerity. "We are excited to be able to offer HealthVerity taXonomy as the industry's most comprehensive, highly-curated and research-ready closed claims dataset premier for the study of efficacy, safety and economic outcomes."

With taXonomy, HealthVerity is taking a bold step towards improving the landscape for healthcare data and delivering transformative results for the industry. To learn more, register for our webinar on Wednesday, July 10 at 12:00 p.m. ET, where we will reveal key details about HealthVerity taXonomy.

HealthVerity introduces taXOnomy℠, the nation's most comprehensive closed (X) and open (O) claims dataset for pharmaceutical research

Thursday, September 26, 2024

PHILADELPHIA, HealthVerity, the leader in synchronizing transformational technologies and real-world data (RWD) to advance the science, today raised the bar by announcing the introduction of HealthVerity taXOnomy, the nation's most expansive, exacting, and efficient closed (X) and open (O) claims dataset to power pharmaceutical research and sophisticated commercial strategies. This integrated data solution can be leveraged for a wider variety of use cases throughout the drug lifecycle – from accelerating commercial strategies and insights to finding ideal clinical trial sites, recruiting optimal patients and developing real-world evidence – providing unmatched clarity into patient journeys with the speed and flexibility that is required to meet today's market challenges.

With the growing need for more complex and personalized medications, it is vital to have the most comprehensive view of the patient journey. The expansive taXOnomy dataset, built on the company's success with its closed claims-focused taXonomy solution, integrates both closed and open claims. It encompasses hundreds of millions of patient lives to span the payer and physician landscape in a single view, often uncovering 25%-65% more patients from the medical benefit than legacy solutions. Furthermore, taXOnomy is designed to be HIPAA-compliant and fully interoperable with lab results, electronic medical records, and hospital chargemaster data to fill key gaps in care and to deliver additional signal for diagnoses, procedures, lab results, and treatments.

HealthVerity taXOnomy meets the pharma industry's exacting standards with an expertly curated data model that yields more accurate and comprehensive outcomes. And where legacy data solutions are plagued by time consuming HIPAA certifications, inconsistent data updates and reporting, and a lack of interoperability with novel data sources, HealthVerity taXOnomy offers a privacy-protected, HIPAA-certified, and research-ready dataset that is fully interoperable with the nation's largest healthcare and consumer data ecosystem. The HealthVerity approach continually supports new payers and is updated daily to provide the most efficient reporting for mission-critical decision making.

"At HealthVerity, we are dedicated to bringing the life sciences industry the most robust data solutions in a frictionless manner, fundamentally enabling better patient outcomes," said Andrew Kress, CEO of HealthVerity. "Our life sciences clients have been advantaged by our groundbreaking closed claims dataset, taXonomy, and have been asking us to assemble the unparalleled coverage, accuracy and interoperability that only HealthVerity taXOnomy can deliver for challenges across the drug development and treatment lifecycle."

To learn more, register for our webinaron Wednesday, September 18 at 12:00 p.m. ET, where we will reveal key details about HealthVerity taXOnomy.